Merck (MRK) Gross Profit (2009 - 2026)
Merck (MRK) posted quarterly Gross Profit of $12.1 billion for Q1 2026, little changed year-over-year from $12.1 billion in Q1 2025, and up 11.45% quarter-over-quarter from $10.8 billion in Q4 2025.
Merck (MRK) Gross Profit (2009 - 2026) Analysis & Trends
Merck (MRK) has reported Gross Profit for 18 consecutive years, with $12.1 billion the latest figure, recorded in Q1 2026.
- In Q1 2026, Gross Profit changed 0.16% year-over-year to $12.1 billion; the TTM figure through Mar 2026 stood at $48.6 billion (changed 0.49% YoY), while the FY2025 annual figure was $48.6 billion, down 0.71% from the prior year.
- Gross Profit improved to $12.1 billion in Q1 2026 per MRK's latest filing, from $10.8 billion in the prior quarter.
- Across five years, Gross Profit topped out at $13.4 billion in Q3 2025 and bottomed at $9.9 billion in Q4 2022.
- Historically, Gross Profit has averaged $11.5 billion across 5 years, with a median of $11.7 billion in 2023.
- Annual changes were most pronounced in 2022 — Gross Profit soared 41.64% — and 2025, when it retreated 8.03%.
- Merck's Gross Profit stood at $9.9 billion in 2022, then climbed by 7.73% to $10.7 billion in 2023, then advanced by 10.06% to $11.8 billion in 2024, then declined by 8.03% to $10.8 billion in 2025, then grew by 11.45% to $12.1 billion in 2026.
- Business Quant data shows MRK's Gross Profit at $12.1 billion in Q1 2026, $10.8 billion in Q4 2025, and $13.4 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.20 Bn | 631.44 Bn | 17.26 Bn |
| 2 | AbbVie | 469.51 Bn | 462.94 Bn | 12.70 Bn |
| 3 | Merck | 376.81 Bn | 369.67 Bn | 12.21 Bn |
| 4 | Novartis Ag | 303.04 Bn | 295.35 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.61 Bn | 252.71 Bn | 12.86 Bn |
| 6 | Amgen | 237.37 Bn | 223.38 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 181.73 Bn | 178.55 Bn | 6.22 Bn |
| 8 | Pfizer | 159.66 Bn | 147.96 Bn | 10.94 Bn |
| 9 | Gsk | 106.24 Bn | 102.07 Bn | 8.24 Bn |
| 10 | Sanofi | 55.07 Bn | 47.69 Bn | 10.79 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 12.21 Bn |
| Jun 30, 2026 | 12.21 Bn |
| Mar 31, 2026 | 12.09 Bn |
| Mar 31, 2026 | 12.09 Bn |
| Dec 31, 2025 | 10.85 Bn |
| Dec 31, 2025 | 10.85 Bn |
| Sep 30, 2025 | 13.42 Bn |
| Sep 30, 2025 | 13.42 Bn |
| Jun 30, 2025 | 12.25 Bn |
| Jun 30, 2025 | 12.25 Bn |
| Mar 31, 2025 | 12.11 Bn |
| Mar 31, 2025 | 12.11 Bn |
| Dec 31, 2024 | 11.80 Bn |
| Dec 31, 2024 | 11.80 Bn |
| Sep 30, 2024 | 12.58 Bn |
| Sep 30, 2024 | 12.58 Bn |
| Jun 30, 2024 | 12.37 Bn |
| Jun 30, 2024 | 12.37 Bn |
| Mar 31, 2024 | 12.24 Bn |
| Mar 31, 2024 | 12.24 Bn |